(Q40174440)

18 September 2017

title

Do natural estrogens pose an increased risk of thrombosis in postmenopausal women? (English)

1 reference

18 September 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A211672

1 June 2022

author name string

S. N. Gitel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A211672

1 June 2022

S. Wessler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A211672

1 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=211672

1 June 2022

publication date

1 August 1978

1 reference

full work available at URL

18 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0049384878900154?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

https://api.elsevier.com/content/article/PII:0049384878900154?httpAccept=text/plain

1 June 2022

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

1 June 2022

1 reference

18 September 2017

volume

13

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

279-283

1 reference

The coronary drug project

18 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

Puerperal thromboembolism and suppression of lactation

1 June 2022

3

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

Investigation of relation between use of oral contraceptives and thromboembolic disease

1 June 2022

4

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

Thromboembolism and oral contraceptives: an epidemiologic case-control study

1 June 2022

5

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

1 June 2022

8

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

Estrogen-containing oral contraceptive agents. A basis for their thrombogenicity

1 June 2022

11

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis

1 June 2022

13

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

Plasma antithrombin III: A quantitative assay of biological activity

1 June 2022

14

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

The rabbit as an animal model for the activated factor X-antithrombin III-heparin reaction

1 June 2022

15

1 reference

https://api.crossref.org/works/10.1016/0049-3848(78)90015-4

1 June 2022

Identifiers

1 reference

18 September 2017

1 reference